SanBio Co Stock

SanBio Co ROE

The Return on Equity (ROE) of SanBio Co (4592.T) as of Aug 7, 2026 is -163.53 %. In the previous year, Return on Equity (ROE) was -94.70 % — a change of 72.69% (lower).

ROE

-163.53 %

YoY

72.69%

Last updated:

In 2026, SanBio Co's return on equity (ROE) was -163.53 %, a 72.69% increase from the -94.70 % ROE in the previous year.

Access this data via the Eulerpool API

SanBio Co Stock analysis

What does SanBio Co do? SanBio Co Ltd is a leading bio-pharmaceutical company focused on the development of products for the treatment of serious neurological diseases. The company was founded in Japan in 2000 and has since become a multinational company with offices in the USA and Europe. Answer: SanBio Co Ltd is a bio-pharmaceutical company that specializes in developing products for the treatment of serious neurological diseases. It was founded in Japan in 2000 and has expanded to become a multinational company with offices in the USA and Europe. SanBio Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding SanBio Co's Return on Equity (ROE)

SanBio Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing SanBio Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

SanBio Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in SanBio Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about SanBio Co stock

Return on Equity (ROE) of SanBio Co is -163.53 % in 2026.

Return on Equity (ROE) of SanBio Co changed from -94.70 % to -163.53 %, representing a 72.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) SanBio Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s SanBio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — SanBio Co

All Key Metrics — SanBio Co